Vertex Pharmaceuticals should fare better in a down market than most stocks. The big biotech innovator has tremendous growth prospects. The stock offers an attractive risk-reward proposition. Vertex ...
From diabetes management to fat-loss fame — Mounjaro has become India’s No. 2 pharma brand. Here’s what you need to know before trying it Mounjaro (tirzepatide), the diabetes drug that turned into ...
A deal is believed to be close to increase the 'value for money' threshold used by England's NHS spending watchdog by 25 per cent. The government has admitted higher prices will be 'necessary' to ...
As India faces renewed scrutiny over the quality of its pharmaceutical products, triggered by the DEG-laced cough syrup deaths of more than a dozen children, Dr Habil Khorakiwala, Chairman of ...
In a setback for Sarepta Therapeutics, a New York panel has voted unanimously to recommend the state Medicaid program pause coverage of a treatment for Duchenne muscular dystrophy.
Toxic cough syrup linked to 17 child deaths in India due to diethylene glycol; drugmakers failed testing norms.
The affected children are from MP's Chhindwara, Rajasthan, and Maharashtra, while states like Kerala and Telangana have issued public alerts banning the use of Coldrif syrup.
The NHS may need to pay more for medicines under plans to stave off tariffs threatened by US president Donald Trump, it has been reported. Politico reported that proposals, including raising the ...
Some Indian pharmaceutical firms failed to follow rules that every batch of medicinal ingredients is tested, the country's drug regulator said on Wednesday, after deaths in the past month of 17 ...
As the industry loses one of its key female leaders in GSK CEO Emma Walmsley, BioSpace profiles the women leading the industry’s smaller biopharmas. With the departure of GSK CEO Emma Walmsley, the ...
An American multinational pharmaceutical company, Merck & Co., Inc. (NYSE:MRK) is one of the most profitable stocks that pay dividends, with a trailing twelve-month net profit margin of 25.8%.